SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong inhibition of the Wnt signaling pathway and antitumor effects as monotherapy and in combination with chemotherapy in triple-negative breast cancer (TNBC) models

被引：0
|
作者：
Chung, Heekyung [1 ]
Sitts, Lauren [1 ]
Creger, Emily [1 ]
John Duc Nguyen [1 ]
Eastman, Brian [1 ]
Mak, Chi-Ching [1 ]
Sunil, K. C. [1 ]
Tam, Betty [1 ]
Bossard, Carine [1 ]
Phalen, Timothy [1 ]
Cha, Steven [1 ]
机构：
[1] Samumed LLC, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-13-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-13-01
引用
收藏
页数：2
相关论文
共 10 条
  • [1] SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong inhibition of the Wnt signaling pathway and antitumor effects in diverse ovarian cancer models.
    Chung, Heekyung
    Sitts, Lauren
    Creger, Emily
    Liao, Erica
    Eastman, Brian
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Bossard, Carine
    Phalen, Timothy
    Cha, Steven
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 41 - 42
  • [2] SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt pathway inhibition in castration-resistant prostate cancer (CRPC) models
    Bossard, Carine
    Cruz, Nathalia
    Chiu, Kevin
    Eastman, Brian
    Mak, Chi Ching
    Sunil, K. C.
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy J.
    Cha, Steven
    CANCER RESEARCH, 2020, 80 (16)
  • [3] SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, downregulates the Wnt signaling pathway and demonstrates antitumor activity in pancreatic cancer cell lines and in vivo xenograft models
    Bossard, Carine
    Cruz, Nathalia
    Eastman, Brian
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy
    Cha, Steven
    CANCER RESEARCH, 2019, 79 (24)
  • [4] SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in Mantle Cell Lymphoma Models
    Chung, Heekyung
    Creger, Emily
    Sitts, Lauren
    Chiu, Kevin
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy
    Cha, Steven
    BLOOD, 2019, 134
  • [5] SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt and cyclin D-CDK4/6-RB pathway inhibition in hormone-receptor-positive (HR plus ) breast cancer models
    Chung, Heekyung
    Sitts, Lauren
    Wu, Chu-Chiao
    Eastman, Brian
    Mak, Chi Ching
    Sunil, K. C.
    Stewart, Josh
    Bossard, Carine
    Phalen, Timothy J.
    Cha, Steven
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Inhibition of tumor growth and post-treatment regrowth by SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, in combination with standard of care in pancreatic cancer models
    Bossard, Carine
    Astsaturov, Igor
    Cruz, Nathalia
    Eastman, Brian
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy
    Cha, Steven
    CANCER RESEARCH, 2019, 79 (24)
  • [7] SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates activity against cancer stem cell (CSC)-enriched pancreatic cancer cells and suppresses stemness in vitro
    Bossard, Carine
    Cruz, Nathalia
    Eastman, Brian
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Phalen, Timothy
    Cha, Steven
    CANCER RESEARCH, 2019, 79 (24)
  • [8] SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in FMS-like Tyrosine Kinase 3 (FLT3)-Mutant Acute Myeloid Leukemia Models
    Chung, Heekyung
    Creger, Emily
    Sitts, Lauren
    Chiu, Kevin
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy
    Cha, Steven
    BLOOD, 2019, 134
  • [9] Effects of SM08502, a novel, oral small-molecule inhibitor of Wnt pathway signaling, on gene expression and antitumor activity in colorectal cancer (CRC) models.
    Bossard, Carine
    Chiu, Kevin
    Chung, Heekyung
    Nguyen, John Duc
    Creger, Emily
    Eastman, Brian
    Mak, Chi Ching
    Do, Long
    Cho, Shawn
    Sunil, K. C.
    Phalen, Timothy
    Tambiah, Jeyanesh
    Cha, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] SM09419, a Novel, Small-Molecule CDC-like Kinase (CLK) Inhibitor, Demonstrates Strong Inhibition of the Wnt Signaling Pathway and Antitumor Effects in Tumor Protein p53 (TP53)-Mutant Acute Myeloid Leukemia Models
    Chung, Heekyung
    Creger, Emily
    Sitts, Lauren
    Chiu, Kevin
    Mak, Chi-Ching
    Sunil, K. C.
    Tam, Betty
    Bucci, Gail
    Stewart, Josh
    Phalen, Timothy
    Cha, Steven
    BLOOD, 2019, 134
1